Director - Diagnostic Execution (Oncology Translational Medicine)

This role is in the Diagnostic Execution Team, which is part of GSK’s Oncology Translational Medicine (OTM) function for Research & Development (R&D).  The team is responsible for operational delivery of clinical biomarker and diagnostic strategies to support GSK's oncology portfolio, working cross-functionally to enable successful implementation of biomarker and diagnostic strategies across clinical development. Key stakes-holder & customer groups include Clinical Development, Clinical Biomarkers, Diagnostic Strategy, Regulatory, Clinical Operations, Quality, Procurement, Data Management, Human Biological Sample Management (HBSM), external CROs and diagnostic partners.   Job-purpose: As Director (Diagnostic Execution) you provide operational leadership for diagnostic activities across GSK's Antibody Drug Conjugate (ADC) portfolio.  Managing a team of Diagnostic Delivery Leads you will be accountable for execution of biomarker and diagnostic strategies (including oversight of external testing partners and delivery of diagnostic milestones) to support clinical development, regulatory submissions, and diagnostic approvals.   The role reports into the Senior Director, Head of Diagnostic Execution and ensures diagnostic activities are delivered to quality, timeline, budget, and regulatory requirements, whilst enabling successful drug-diagnostic co-development.     Key Responsibilities (include..): • Managing operational delivery of biomarker and diagnostic activities for patient selection or stratification across the ADC portfolio, ensuring alignment between therapeutic development plans and diagnostic deliverables and oversee diagnostic timelines, budgets, assay performance metrics, risks and mitigation plans. • Provide operational leadership to diagnostic programs (from assay development through regulatory approval).  This includes partnering with Diagnostic leads, Clinical Development, Regulatory Affairs, and diagnostic manufacturers (to support drug-diagnostic co-development). • Lead relationships with external parties (including laboratories, CROs, central laboratories, and diagnostic manufacturers).  This extends to overseeing vendor selection (eg; contracting, governance, performance management, and quality compliance) and the successful global deployment of diagnostic assays and achievement of operational performance. ·       Drive operational excellence, continuous improvement, inspection readiness, and compliance with GCP, GDPR, and global regulatory requirements.     Location: Stevenage (UK) or Upper Providence (USA).   Please Note: If the successful applicant is based at Stevenage site: This role will temporarily be based at Stevenage.  However, the Company plans to relocate its offices to Cambridge, UK. The location of this role will therefore subsequently change to Cambridge UK, in accordance with timelines to be set by the Company.  The relocation is currently proposed to take effect by early 2029.     About GSK: At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the immune system with cutting-edge technology to transform people’s lives. GSK fosters a culture ambitious for patients, accountable for impact, and committed to doing the right thing, making sure that we focus our efforts on accelerating significant assets that meet patients’ needs and have the highest probability of success. We’re uniting science, technology, and talent to get ahead of disease together.  Find out more - our approach to R&D:  https://www.gsk.com/en-gb/innovation/     APPLICATION CLOSING DATE – Monday 2 nd of November 2026 (COB).     Basic Qualifications: • R